查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654726

全球光療設備市場 - 2025 至 2033 年

Global Phototherapy Equipment Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球光療設備市場規模達到 5.2121 億美元，預計到 2033 年將達到 7.4652 億美元，2025-2033 年預測期內的複合年成長率為 4.8%。

全球光療設備市場包括使用特定波長的光來治療各種皮膚狀況和疾病的設備和系統。這種醫療方法通常稱為光療法或光療，可有效治療多種疾病，包括牛皮癬、濕疹和白斑症。

牛皮癬是一種慢性自體免疫疾病，其特徵是皮膚細胞快速增殖，導致出現厚、紅、鱗狀斑塊。光療法透過將皮膚暴露在紫外線 (UV) 下來幫助控制這種情況，這可以減緩過多的皮膚細胞生成並減少發炎。濕疹，或稱為異位性皮膚炎，是一種常見的發炎性皮膚病，導致皮膚發紅、發癢和發炎。光療法可以減輕發炎和瘙癢，對濕疹患者有益。

白斑症是一種皮膚病，其特徵是黑色素細胞被破壞導致斑塊中色素脫落。光療法，尤其是窄頻 UVB 療法，可以刺激患處的色素重新沉澱。新生兒黃疸是新生兒常見的疾病，由血液中膽紅素過多引起，導致皮膚和眼睛發黃。光療法是這種病症的標準治療方法；該方法包括將嬰兒置於專門的藍光下，幫助分解皮膚中的膽紅素，促進其排泄。

由於人們對這些情況的認知不斷提高和光療技術的進步，全球光療設備市場正在經歷顯著成長。基於 LED 的系統和光纖設備等設備由於其有效性和安全性而變得越來越普遍。這些因素推動了全球光療設備市場的擴張。

市場動態：

促進因素與約束因素

光療技術的創新

目前，全球光療設備市場正見證光療技術創新所推動的重大進步。這些進步正在提高治療效果、病人安全性以及光療解決方案的整體可近性。

轉向基於 LED 的光療設備是市場的重要趨勢。 LED 具有高效率、高耐用性，並且能夠發射治療各種皮膚病所需的特定波長的光。與傳統螢光燈相比，它們的維護需求低且能耗低，可提高治療效果，同時降低醫療服務提供者的營運成本。

家庭醫療保健的興起刺激了患者可在家中使用的攜帶式光療設備的發展。這種趨勢對於新生兒黃疸和慢性皮膚病等需要持續治療的疾病尤其重要。家庭護理解決方案提供了便利，減少了去醫院的頻率，並使患者能夠更有效地管理自己的病情。

此外，業界主要參與者推出的創新產品將推動全球光療設備市場的成長。這些設備利用紅光和近紅外光療法提供廣泛的健康益處，使不同群體都能使用。

此外，2024 年 6 月，Dermalux 在倫敦科文特花園 IceTank 舉行的發表會上推出了創新 LED 光療治療系統 Tri-Wave MD MK II。這款先進的設備經過專門設計，可為大面積皮膚提供有效的光療，適合各種皮膚狀況。所有這些因素都要求全球光療設備市場的發展。

此外，對智慧技術整合的需求不斷成長，促進了全球光療設備市場的擴張。

與治療相關的風險因素

與 UVB 和 PUVA 療法相關的併發症對全球光療設備市場造成了重大限制，因為它們會對患者安全和治療接受度產生不利影響。根據美國國家生物技術資訊中心 (NCBI) 2024 年 2 月的資料，UVB 療法的急性影響包括紅斑和灼熱感，通常在 12 至 24 小時內達到峰值，並且對於皮膚類型較白或服用某些藥物的人來說可能更為嚴重。

慢性併發症可導致光老化，其特徵是皮膚乾燥、起皺和皮膚脆弱性增加，同時寬頻和窄帶 UVB 療法之間具有不同的潛在致癌風險。 PUVA 療法還具有光毒性等急性風險，導致長時間的紅斑、噁心和罕見的指甲損傷，而慢性影響可能包括 PUVA 雀斑、鱗狀細胞癌風險增加以及由於補骨脂素在眼晶狀體中積聚而可能導致白內障發展。因此，上述因素可能會限制全球光療設備市場的潛在成長。

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動態

  • 影響因素
    • 驅動程式
      • 光療技術的創新
    • 限制
      • 與治療相關的風險因素
    • 機會
    • 影響分析

第5章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第 6 章：依產品類型

  • 常規光療設備
    • 全身光療設備
    • 局部身體光療設備
    • 常規螢光燈光療設備
    • 配有緊湊型螢光燈的傳統光療設備
  • LED光療設備
  • 光纖光療設備
  • 殺菌燈
  • 配件

第 7 章：按輻射類型

  • UVA（紫外線A
  • UVB（紫外線B）
  • UVC（紫外線C）

第 8 章：按應用

  • 皮膚病治療
    • 牛皮癬
    • 濕疹
    • 白斑
    • 粉刺
    • 其他
  • 新生兒黃疸管理

第 9 章：按最終用戶

  • 醫院及專科診所
  • 皮膚科中心
  • 其他

第 10 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 11 章：競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 併購分析

第 12 章：公司簡介

  • GE Healthcare
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售量
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 關鍵進展
      • 合併與收購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT 分析
  • Philips
  • Natus Medical Incorporated
  • Phoenix Medical Systems.
  • Atom Medical Corp.
  • Nice Neotech Medical Systems Pvt. Ltd.
  • NatBio.
  • Solarc Systems Inc.
  • The Daavlin Company
  • MTTS.

第 13 章：附錄

簡介目錄
Product Code: MD1626

The global phototherapy equipment market reached US$ 521.21 million in 2024 and is expected to reach US$ 746.52 million by 2033, growing at a CAGR of 4.8 % during the forecast period 2025-2033.

The global phototherapy equipment market includes devices and systems that use specific wavelengths of light to treat various skin conditions and disorders. This medical treatment, commonly known as phototherapy or light therapy, effectively addresses a range of conditions, including psoriasis, eczema, and vitiligo.

Psoriasis is a chronic autoimmune disease characterized by the rapid proliferation of skin cells, resulting in thick, red, and scaly patches. Phototherapy helps manage this condition by exposing the skin to ultraviolet (UV) light, which can slow down the excessive skin cell production and reduce inflammation. Eczema, or atopic dermatitis, is a prevalent inflammatory skin condition that leads to red, itchy, and inflamed skin. Phototherapy can be beneficial for individuals with eczema by reducing inflammation and itching.

Vitiligo is a skin disorder marked by the loss of pigment in patches due to the destruction of melanocytes. Phototherapy, particularly narrowband UVB therapy, can stimulate repigmentation in affected areas. Neonatal jaundice is a common condition in newborns caused by an excess of bilirubin in the blood, leading to yellowing of the skin and eyes. Phototherapy is a standard treatment for this condition; it involves placing the infant under specialized blue lights that help break down bilirubin in the skin, facilitating its excretion.

The global phototherapy equipment market is witnessing significant growth due to increasing awareness of these conditions and advancements in phototherapy technology. Devices such as LED-based systems and fiber-optic equipment are becoming more prevalent due to their effectiveness and safety features. These factors have driven the global phototherapy equipment market expansion.

Market Dynamics: Drivers & Restraints

Innovations in Phototherapy Technology

The global phototherapy equipment market is currently witnessing substantial advancements propelled by innovations in phototherapy technology. These advancements are improving treatment effectiveness, patient safety, and overall accessibility to phototherapy solutions.

The shift towards LED-based phototherapy devices is a significant trend in the market. LEDs offer high efficiency, durability, and the capability to emit specific wavelengths of light necessary for treating various skin conditions. Their low maintenance needs and reduced energy consumption make them preferable over traditional fluorescent lamps, enhancing treatment outcomes while lowering operational costs for healthcare providers.

The rise in home healthcare has spurred the development of portable phototherapy devices that patients can use at home. This trend is particularly relevant for conditions like neonatal jaundice and chronic skin disorders, where continuous treatment is essential. Homecare solutions provide convenience, reduce the frequency of hospital visits, and empower patients to manage their conditions more effectively.

Furthermore, key players in the industry innovative product launches that would drive this global phototherapy equipment market growth.For instance, in April 2024, Bestqool launched a new line of portable red light therapy devices, specifically engineered for effective and convenient use at home. These devices utilize red and near-infrared light therapy to offer a wide range of health benefits, making them accessible to a diverse audience.

Also, in June 2024, Dermalux introduced the Tri-Wave MD MK II, an innovative LED phototherapy treatment system, during a launch event held at IceTank in Covent Garden, London. This advanced device is specifically engineered to deliver effective light therapy over extensive skin areas, making it suitable for a variety of skin conditions. All these factors demand the global phototherapy equipment market.

Moreover, the rising demand for the integration of smart technologies contributes to the global phototherapy equipment market expansion.

Risk Factors Associated with the Treatment

The complications associated with UVB and PUVA therapy present significant restraints in the Global Phototherapy Equipment Market, as they can adversely affect patient safety and treatment acceptance. According to the National Center for Biotechnology Information (NCBI) data in February 2024, acute effects of UVB therapy include erythema and burning sensations, which typically peak within 12 to 24 hours and may be more severe in individuals with lighter skin types or those on certain medications.

Chronic complications can lead to photoaging, characterized by dry skin, wrinkling, and increased skin fragility, alongside potential carcinogenic risks that differ between broadband and narrowband UVB therapies. PUVA therapy also carries acute risks such as phototoxicity, resulting in prolonged erythema, nausea, and rare nail damage, while chronic effects may include PUVA lentigines, an elevated risk of squamous cell carcinoma, and potential cataract development due to psoralen accumulation in the ocular lens. Thus, the above factors could be limiting the global phototherapy equipment market's potential growth.

Segment Analysis

The global phototherapy equipment market is segmented based on product type, radiation type, application, end-user, and region.

Product Type:

The conventional phototherapy equipment segment is expected to dominate the global phototherapy equipment market share

The conventional phototherapy equipment segment holds a major portion of the global phototherapy equipment market share and is expected to continue to hold a significant portion of the global phototherapy equipment market share during the forecast period.

The global phototherapy equipment market includes a diverse range of devices specifically designed for the effective treatment of skin conditions and neonatal jaundice. A significant segment within this market is conventional phototherapy equipment, which can be categorized into several types, including full-body phototherapy equipment, partial-body phototherapy equipment, conventional phototherapy equipment with fluorescent lamps, and conventional phototherapy equipment with compact fluorescent lamps.

Conventional phototherapy equipment primarily utilizes light sources such as fluorescent lamps and compact fluorescent lamps to deliver therapeutic light. These devices are widely utilized in clinical settings due to their proven effectiveness and affordability in treating conditions like psoriasis, eczema, vitiligo, and neonatal jaundice. Their established presence in healthcare facilities highlights their importance in dermatological care.

Conventional phototherapy equipment includes full-body phototherapy equipment, partial-body phototherapy equipment, conventional phototherapy equipment with fluorescent lamps, and conventional phototherapy equipment with compact fluorescent lamps. Full-body phototherapy units are designed to expose the entire body to therapeutic light, making them particularly effective for treating extensive skin conditions or managing neonatal jaundice in infants. Partial-body phototherapy equipment is tailored for localized treatment of specific areas affected by skin conditions.

Conventional phototherapy equipment with fluorescent lamps this category includes devices that utilize traditional fluorescent lamps as their primary light source. Compact fluorescent lamps (CFLs) represent a modern advancement within the conventional phototherapy segment. CFLs are smaller and more energy efficient than traditional fluorescent tubes while producing higher irradiance levels.

Furthermore, key players in the industry have key initiatives and innovative product launches that would propel this segment's growth in the global phototherapy equipment market. For instance, in September 2024, Best Choice Specialist Hospital unveiled the first intensive infant phototherapy machine in Kano, Nigeria. This cutting-edge equipment is specifically designed to effectively treat jaundice in newborns, representing a significant advancement in neonatal care for the region. The introduction of this machine aims to enhance healthcare solutions for infants suffering from jaundice, improving treatment capabilities at the hospital and providing families with better access to essential medical care.

Also, in November 2023, GlobalMed Technologies introduced the Omnilux Mini, a new line of three FDA-cleared LED devices designed for targeted skincare treatments. Each device is distinguished by its flexibility, portability, and affordability, retailing at $95. The Omnilux Mini utilizes red, near-infrared, and blue LEDs to effectively tackle various skin issues, including fine lines, wrinkles, acne, and overall skin health. These factors have solidified the segment's position in the global phototherapy equipment market.

Geographical Analysis

North America is expected to hold a significant position in the global phototherapy equipment market share

North America holds a substantial position in the global phototherapy equipment market and is expected to hold most of the market share. The rising incidence of skin diseases, including psoriasis, eczema, and vitiligo, is a major driver for the phototherapy equipment market in North America. As more individuals seek effective treatment options for these conditions, the demand for advanced phototherapy solutions continues to grow. Increased awareness and improved diagnosis of these disorders contribute to higher treatment rates, further boosting market demand.

Neonatal jaundice is a common condition among newborns that leads to increased demand for phototherapy devices specifically designed to manage this issue. Phototherapy has become a standard treatment option in hospitals and clinics across the region due to its effectiveness in reducing bilirubin levels in infants. The consistent need for these treatments ensures a steady market for phototherapy equipment.

Technological innovations in phototherapy equipment, particularly the development of LED-based systems, have significantly improved treatment efficacy and safety. These advancements include features such as remote monitoring and adjustable light intensity, which enhance patient care and convenience. As healthcare providers increasingly adopt these advanced technologies, the market for phototherapy equipment expands.

Furthermore, in this region, a major number of key players present, well-advanced healthcare infrastructure, and innovative product launches that would drive this global phototherapy equipment market growth. For instance, in June 2023, GlobalMed Technologies (GMT) unveiled a new line of topical skincare products designed to enhance the effectiveness of its clinically proven LED light therapy treatments, specifically the Omnilux Contour Face and Omnilux Men. This launch highlights GMT's dedication to innovation in the field of aesthetic dermatology. Thus, the above factors are consolidating the region's position as a dominant force in the global phototherapy equipment market.

Asia Pacific is growing at the fastest pace in the global phototherapy equipment market share

Asia Pacific holds the fastest pace in the global phototherapy equipment market and is expected to hold most of the market share. The increasing prevalence of skin conditions such as psoriasis and eczema are a significant catalyst for the phototherapy equipment market in Asia-Pacific. Growing awareness of these disorders has led more individuals to seek effective treatment options, thereby boosting demand for advanced phototherapy solutions.

Neonatal jaundice remains a common condition among newborns, leading to heightened demand for specialized phototherapy devices. The effectiveness of phototherapy in lowering bilirubin levels has made it a standard treatment in hospitals and clinics throughout the region. The growing geriatric demographic in countries like Japan and South Korea is contributing to the demand for phototherapy devices. Older adults are more susceptible to skin conditions requiring treatment, creating a significant market opportunity for manufacturers.

Innovations in technology, particularly the emergence of LED-based systems, have notably improved the efficacy and safety of phototherapy devices. Features such as remote monitoring and adjustable light intensity enhance patient care and convenience, further encouraging the adoption of these advanced technologies.

Furthermore, key players in the industry initiatives and government-supportive activities would drive this global phototherapy equipment market growth. For instance, in October 2024, the recent inauguration of new healthcare facilities at the All-India Institute of Medical Sciences (AIIMS)-Patna, including the expansion of its neonatal intensive care unit (NICU) from eight to 24 beds, highlights the increasing demand for advanced healthcare solutions.

This demand is particularly evident in the phototherapy equipment market, which is experiencing substantial growth due to rising cases of neonatal jaundice and skin disorders that phototherapy effectively addresses. Thus, the above factors are consolidating the region's position as the fastest-growing force in the global phototherapy equipment market.

Competitive Landscape

The major global players in the phototherapy equipment market include GE Healthcare, Philips, Natus Medical Incorporated, Phoenix Medical Systems., Atom Medical Corp., Nice Neotech Medical Systems Pvt. Ltd., NatBio., Solarc Systems Inc., The Daavlin Company, and MTTS. among others.

Key Developments

  • In March 2024, Celluma Light Therapy unveiled the Celluma CONTOUR, an innovative body contouring device that has gained significant attention for being the first LED light therapy system to receive FDA clearance for over-the-counter body contouring. This milestone represents a major advancement in non-invasive aesthetic treatments, offering consumers an effective and accessible option for body sculpting.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global phototherapy equipment market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Radiation Type
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Innovations in Phototherapy Technology
    • 4.1.2. Restraints
      • 4.1.2.1. Risk Factors Associated with the Treatment
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Force Analysis
  • 5.7. Supply Chain Analysis
  • 5.8. Patent Analysis
  • 5.9. SWOT Analysis
  • 5.10. Unmet Needs and Gaps
  • 5.11. Recommended Strategies for Market Entry and Expansion
  • 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.13. Pricing Analysis and Price Dynamics
  • 5.14. Key Opinion Leaders

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Conventional Phototherapy Equipment*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Full-body Phototherapy Equipment
    • 6.2.4. Partial-body Phototherapy Equipment
    • 6.2.5. Conventional Phototherapy Equipment with Fluorescent Lamp
    • 6.2.6. Conventional Phototherapy Equipment with Compact Fluorescent Lamp
  • 6.3. LED Phototherapy Equipment
  • 6.4. Fiberoptic Phototherapy Equipment
  • 6.5. Germicidal Lamps
  • 6.6. Accessories

7. By Radiation Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Radiation Type
    • 7.1.2. Market Attractiveness Index, By Radiation Type
  • 7.2. UVA (Ultraviolet A*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. UVB (Ultraviolet B)
  • 7.4. UVC (Ultraviolet C)

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Skin Disease Treatment*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 8.2.3. Psoriasis
    • 8.2.4. Eczema
    • 8.2.5. Vitiligo
    • 8.2.6. Acne
    • 8.2.7. Others
  • 8.3. Neonatal Jaundice Management

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals & Specialty Clinics*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Dermatology Centers
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Radiation Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Radiation Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Radiation Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Radiation Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Radiation Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. GE Healthcare*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio
      • 12.1.2.1. Product Description
      • 12.1.2.2. Product Key Performance Indicators (KPIs)
      • 12.1.2.3. Historic and Forecasted Product Sales
      • 12.1.2.4. Product Sales Volume
    • 12.1.3. Financial Overview
      • 12.1.3.1. Company Revenue's
      • 12.1.3.2. Geographical Revenue Shares
      • 12.1.3.3. Revenue Forecasts
    • 12.1.4. Key Developments
      • 12.1.4.1. Mergers & Acquisitions
      • 12.1.4.2. Key Product Development Activities
      • 12.1.4.3. Regulatory Approvals etc.
    • 12.1.5. SWOT Analysis
  • 12.2. Philips
  • 12.3. Natus Medical Incorporated
  • 12.4. Phoenix Medical Systems.
  • 12.5. Atom Medical Corp.
  • 12.6. Nice Neotech Medical Systems Pvt. Ltd.
  • 12.7. NatBio.
  • 12.8. Solarc Systems Inc.
  • 12.9. The Daavlin Company
  • 12.10. MTTS.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us